SCHEMBL21189321

SCHEMBL21189321

O=C(Cl)c1cccc2c1SCCC2=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VHL P40337 1/20 0.38
ELOC Q15369 1/20 0.38
ELOB Q15370 1/20 0.38
ALDH1A1 P00352 4/20 0.34
ALOX15 P16050 1/20 0.34
PARP1 P09874 1/20 0.33
FOLH1 Q04609 1/20 0.33
KDM4E B2RXH2 2/20 0.33
HTT P42858 1/20 0.33
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
S100A4 P26447 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GLA P06280 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30
LMNA P02545 1/20 0.30
CYP2A6 P11509 1/20 0.30
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325775 0.85 ALDH1A1 (0.41) VHLELOCELOBALDH1A1ALOX15
SCHEMBL20509864 0.83 ALDH1A1 (0.36) ALDH1A1ALOX15PARP1MAPTMEN1
SCHEMBL10464 0.76 MAPT (0.46) VHLELOCELOBALDH1A1ALOX15
SCHEMBL5635241 0.73 MEN1 (0.47) VHLELOCELOBALDH1A1PARP1
SCHEMBL6924 0.73 NOTUM (0.39) VHLELOCELOBALDH1A1KDM4E
SCHEMBL7502 0.73 PARP10 (0.39) VHLELOCELOBALDH1A1FOLH1
SCHEMBL21189396 0.72 ALDH1A1 (0.36) VHLELOCELOBALDH1A1ALOX15
SCHEMBL24188888 0.70 ALDH1A1 (0.44) VHLELOCELOBALDH1A1KDM4E
SCHEMBL7101648 0.69 MAPT (0.50) ALDH1A1MAPTKMT2AS100A4SMN1; SMN2
SCHEMBL8473139 0.69 KDM4E (0.36) VHLELOCELOBALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS VHL 164/4885ELOC 651/4885ELOB 528/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS VHL 164/4885ELOC 651/4885ELOB 528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.